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Pruritus can be a most difficult symptom to treat and much effort has been
expended to find a safe and effective antipruritic agent. Many cutaneous dis-
eases (urticaria, angioneurotic edema, atopic dermatitis and others) associated
with pruritus are thought to be related to the action of histamine or related
substances, and so the search has been mainily directed to the development of
anti-histamine drugs. The reports by Loew, Kaiser and Moore (1) and the
chrncal findings of Curtis and Owens (2—3) and Shaffer, Carrick and Zackheiin
(4) and Todd (5) indicate that Benadryl (beta dimethylaminoetbyl benzhydryl
ether hydrochloride) may produce the desired effects. An excellent review of
the chemical properties, anti-histamine action and some of the clinical value of
Benadryl is the symposium on the subject from the staff meetings of the Mayo
Clinic (6). The study of any new drug is often speculative, since neither the
optimum dosage nor the diseases which should be treated can be predicted.
Furthermore, side reactions might occur which had not heretofore been men-
tioned by other observers. With this in mind, the present study was started
and each case was followed at short intervals. The patients were all adults,
ranging in age from eighteen to sixty; seventy per cent were males and twenty
per cent were bed patients.
The nature of Benadryl has been fully discussed in the Mayo Symposium.
"Loew and his associates studied twenty one benzhydryl ethers and amines by a test
which determined the degree of protection each compound gave against bronchospasm in-
duced in guinea pigs by an exposure to an atmosphere containing atomized solution of
histamine. Three of the benzhydryl ethers were found to have anti-histamine activity and
low toxicity of which beta dimethylaminoethyl benzhydryl ether hydrochloride was the
most promising. Later Loew and his co-workers demonstrated that previous treatment
with Benadryl reduced the severity of anaphylactic shock in guinea pigs." (Code, 6). The
toxicity of Benadryl is low and there is a wide range between the therapeutic and seriously
toxic effects of the drug. It is a white crystalline powder, soluble in water and alcohol and
* Benadryl was supplied through the courtesy of Parke Davis & Co., Dept. of Clinical
Investigation, Detroit, Mich., U. S. A.
t Since the preparation of this report another drug with similar action to Benadryl has
been made generally available, and has received extensive study. This is Pyribenzamine
(trade name of the Ciba Pharmaceutical Co.) (See, for example, Baer and Sulzberger,
Ref. 7.)
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stable under ordinary conditions of temperature and atmosphere. Its structural
formula is:
CHOCH2 CH2N( CH,)2HCI
Prior to release of the drug for civilian use and aside from the patients reported in the
present paper, 2266 patients with 71 different disease entities were treated with Benadryl
and in no instance was a cumulative effect or permanent ill-effect noted. No changes in the
hemogram of patients who had taken one hundred to two hundred mg. of the drug daily for
six months and no febrile reactions or skin eruptions were reported. Benadryl is readily
absorbed by all routes of administration and the maximum response following oral
use is about twenty-five minutes, though it may be as rapid as ten minutes. The thera-
peutic action usually lasts from five to eight hours. After parenteral use the response
manifests itself in three to ten minutes and the effects last four to five hours.
The Mayo report listed the following side effects: seventy-four cases showed sleepiness,
dizziness, feeling of nervousness, dry mouth, urinary frequency, fatique, epigastric distress,
difficulty in co-ordination, nausea, bad tast, bleeding tendency (?),sense of relaxation.
The premature appearance of an article on Benadryl in a lay periodical may have led
patients and physicians alike to expect true miracles from benadryl. Since this article
dealt mostly with allergy, it may have deterred the study of this drug in other fields of medi-
cine. Furthermore, at the time of the lay report, Benadryl had not been tried sufficiently
long to permit definite conclusions to be drawn as to its effectiveness.
The present study, started January, 1946, at Oliver General Hospital, ex-
tended to June, 1946. All of the patients except one had a dermatonis associ-
ated with pruritus. There were 19 different skin diseases and 1 case of gastric
crises. The untoward reactions were: drowsiness (80 per cent of the patients);
sleepiness (40 per cent); dizziness, blurring of vision, state of excitement, dry
mouth, nausea and vomiting, loss of appetite, increase in appetite, numbness of
the extremities, and depressive state (1 case). The drug was given in 50 to 100
milligram capsules orally from 3 times a day to 1 every 4 hours. Some patients
received the preparation every 4 hours day and night for 2 and 3 weeks, while
others took 2 or 3 capsules a day for 6 months. These doses produced no
changes in the blood or urine. No cutaneous intolerance was encountered in this
series.
An analysis of the results of Benadryl therapy and some short case summaries
follow:
Urticaria
Curtis and Owens treated 18 patients with various types of urticarial eruptions and
stated that 14 patients were improved. Chronic urticaria disappeared when Benadryl was
administered, but it recurred promptly when the drug was stopped. Shaffer, Carrick and
Zackheim reported favorable response in 7 of 8 cases of both acute and chronic urticaria.
O'Leary stated that the lesions in 25 of 35 cases of chronic urticaria disappeared com-
pletely save for the occasional presence of a few nonpruritic wheals. Seven cases were del-
nitely improved and 3 were not benefited. All of fhse patients had chronic urticaria of
which the shortest duration was 4 months and the average duration was 4 years. Of 15
TREATMENT OF DERMATOSES WITR BENADRYL 303
patients with acute urticaria, 9 experienced prompt relief in from 20 to 60 minutes, 5 im-
proved and 1 failed to respond to treatment. Todd treated 52 cases of urticaria and stated
the results following treatment with benadryl were prompt and quite amazing. Forty-
seven patients were completely relieved, 4 were partially relieved and 1 relieved of wheals
but not of pruritus.
In our series, 54 patients with urticaria were treated and classified as follows:
Thirty-nine of the cases were acute, with an average duration of about 8 days;
15 cases were chronic with an average duration of 9 months. As noted in Figure
TABLE 1
Rezults of benadryl therapy
TOTAL IMPROVEMENTDEFINITE
IMPROVEMENT
MODERATE FAILURE
1. Urticaria 54 34 16 4
2. Dermographism 8 5 2 1
3. Atopic Dermatitis 3 2 1
4. Dermatitis Venenata 29 14 7 8
5. Dermatitis Medicamentosa 16 9 6 1
6. Dermatophytosis with "id" reac-
tion 3 1 1 1
7. Herpes Zoster 3 3
8. Dermatitis Herpetiformis 1 1
9. Scrotal Pruritus 5 3 1 1
10. Anal Prurjtus 9 4 3 2
11. Mycosis Fungoides 1 1
12. Idiopathic Pruritus 2 1 1
13. Dysidrosis 8 3 3 2
14. Pityriasis Rosea with Pruritus. . . 2 2
15. Exfoliating Dermatitis 1 1
16. Seborrheic Dermatitis with Pruri-
tus 1 1
17. Insect Bites 10 6 3 1
18. Miliaria 7 4 1 2
19. Post-Scabetic Pruritus 6 3 2 1
20. Gastric Crises 1 1
170 97 48 25
I, 16 patients had a moderate improvement with diminution of pruritus and
lesions. Thirty-four patients had definite improvement and the urticarial
lesions disappeared completely save for the occasional presence of a non-pruritic
wheal. Relief from pruritus was almost dramatic and usually occurred in about
fifteen to thirty-five minutes after institution of treatment. Three of the 4
complete failures occurred in patients with chronic urticaria. In many of our
cases other methods of treatment had been used without success. An interesting
observation was the fact that though the pruritus disappeared, non-pruritic
erythematous lesions continued to appear. This suggests that the histamine is
probably not neutralized with average dosage of Benadryl and that there may
also be an anti-acetyicholine effect. Twenty-five per cent of the patients with
304 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
acute urticaria had an associated angioneurotic edema which also responded.
Eighty per cent of the acute cases cleared up completely and often no more than
12 capsules were given. On the other hand, as soon as therapy was discontinued
the lesions in the chronic cases promptly recurred. In one case of acute urticaria
the lesions appeared during the meal, while the patient was eating lobster.
The itching became rather severe and 1 hour later 1 fifty milligram capsule of
Benadryl was given; within 35 minutes there was permanent disappearance Gf
the pruritus and lesions.
The dosage of Benadryl for urticaria varies with the severity of the reaction.
In a case of angio-neurotic edema following diptheria toxoid the drug was given
in 50 milligram dosage every 4 hours day and night, but had to be increased to
100 milligrams for the same period of time before the condition was controlled.
Although we have not tried it, it might be useful to try Benadryl as a prophy-
lactic in individuals sensitive to specific food.
Acute urticaria responds more promptly to Benadryl than does the chronic
form. Although acute urticaria may subside spontaneously the degree of dis-
comfort is often great and Benadryl offers these patients a definite crutch in its
ability to relieve them of the associated severe pruritus. It definitely breaks
the urticarial cycle and often after a few days of treatment no new lesions ap-
pear in the greater majority of the cases. On the other hand, as stated above,
it appears that patients with chronic urticaria are relieved only while the drug
is actually being administered. Symptoms promptly recurred when the drug
was discontinued and in no instance was a cure obtained; nevertheless, the re-
lief from the pruritus and lesions was greatly appreciated by the patients.
Dermographism responds less dramatically and the drug usually had to be
taken 3 to 4 days before any change was noted. At that time the patient sus-
tained relief from the pruritus and a lessening in wheal formation after stroking
or scratching the skin. The wheal formation, however, never disappeared and
as soon as the drug was discontinued all signs and symptoms promptly re-
curred. These patients, however, did not seem to have as marked untoward
reactions as the patients with acute and chronic urticaria and angioneurotic
edema. They also appeared to tolerate larger doses of the drug.
A topic dermatitis: Three patients with extensive atopic dermatitis obtained
encouraging results. Two of them were followed for over 6 months and 1 for
18 months prior to treatment with Benadryl. They had been resistant to a
variety of treatments including roentgen therapy. Benadryl in fifty milligram
capsules was given every 4 hours, day and night, for about 96 hours before any
definite relief from the pruritus was noted. With the cessation of the pruritus,
the patients gradually became encouraged. After 3 months of Benadryl therapy,
2 patients were markedly improved; pruritus was only occasionally present and
thickening of the skin was reduced. Although they were not entirely free of
skin lesions, the patients were able to continue their routine duties with little
discomfort.
One of these patients, the wife of a soldier, also had associated asthma and hay
fever. There was definite improvement in both of these latter conditions. She
bad been treated while her husband was overseas and became so discouraged by
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tne appearance of her skin that she did not wish to see him on his return. Six
months after his return Benadryl was obtained, and after a short time his wife
was a changed person. She was able to take 50 milligram capsules every four
hours during the day and occasionally at night for 6 nrnnths without any serious
effects. Her only complaints were occasional drowsiness, dry mouth and a def-
inite sense of relaxation.
Dermatitis venenata: Twenty-nine patients with various forms of contact
dermatitis treated with Benadryl yielded variable results. Although no change
was affected in the physical appearance of the eruption, pruritus was decreased
and secondary infection was reduced. Dermatitis from rhus toxicodendron
responded more definitely than did contact reactions to soap, leather, oils, greases
or benzenes. Seventy-five per cent of the former patients noted relief from
pruritus in the first 24 hours. Their response to local treatment was much more
rapid than those who failed to respond to Benadryl.
Another type of contact dermatitis which reacted favorably to Benadryl was
that caused by penicillin. Six of the 29 cases treated were caused by this anti-
biotic (4 from local use and 2 from contact in the preparation and administration
of penicillin).
Dermatitis medicamentosa: Sixteen cases of drug allergy were treated with
Benadryl. Not only did the pruritus disappear, but the patients were better
able to tolerate the offending drug and in no instance was the drug discontinued
after an eruption or pruritus appeared. The following drugs caused reactions:
sulfathiazole, 2 cases; anthiomaline, 1 case; chioroquine (SN 7618), 2 cases;
atabrine, 1 case; and penicillin, 10 cases. The penicillin cases were of 4 types:
diffuse erythema, acute urticaria, angioneurotic edema and small vesicles on the
bands, feet, perianal and crural areas. The pruritus in these patients disap-
peared dramatically and in 1 patient, an army nurse, scarcely recognizable be-
cause of severe angioneurotic edema of the face, eyelids, lips and extremities,
there was a complete return to normal in 3 days. Definite alleviation of the
pruritus was noted after the first capsule and dhnunition of the edema after the
third capsule. Each capsule was taken at 4 hour intervals. One patient with
metastatic lesions of granuloma inguinale developed dermatitis of the body and
extremities after the sixth injection of 3.0 cc. of anthiomaline given intramus-
cularly. The anthiomaline injections were stopped and Benadryl was given
for 5 days. At the end of this time the anthiomaline was readmiistered and the
patient has since received 24 injections with little reaction.
If these observations are confirmed it may enable drug sensitive individuals in
dire need of certain drugs to use them with safety. In such cases, Benadryl
may be tried beforehand to reduce known drug sensitivity.
Herpes zoster: Three cases of herpes zoster were treated with Benadryl and
their results warrant its further trial. Within 7 to 10 days their associated
pruritus had disappeared, the attendant pain had markedly diminished and in
only 1 patient was a mild amount of discomfort still present. No other form of
treatment was given and each case received one 50 milligram capsule every 4
hours during the day and 1 at night if necessary.
Anal and scrotal prutitus: Seven of 14 patients with this complaint had definite
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improvement from Benadryl. This process was the most refractory of all
treated. In addition, it was difficult to evaluate the results, inasmuch as certain
of the individuals had a fixation neurosis. None of the patients had any as-
sociated disease, such as fungous infection, psoriasis, lichen planus, hemorrhoids,
etc.
Miliaria: Definite subjective improvement was noted in 5 of 7 patients who
had received the drug. It might have been of importance that all of the patients
were seen during the first 24 to 48 hours of this disease.
Insect bites: Ten patients with single and multiple insect bites were treated
and only 1 failure was noted. Three cases had some degree of improvement and
6 were markedly improved.
Dermatitis herpetiformis: One case hypersensitive to sulfapyridine, observed
for 4 months, sustained alleviation of better than 80 per cent of the pruritus all
the time. There was recurrence of the pruritus when l3enadryl was withheld.
Miscellaneous dermatoses: (a) One patient with mycosis fungoides of several
months duration was treated with 100 milligrams of Benadryl every 6 hours day
and night for one week without benefit. (b) Two patients with pityriasis rosea
and associated pruritus had definite relief and the eruption appeared to clear
more quickly than with only local lotion. (c) Eight patients with marked
dysidrosis were treated with relief of the pruritus in more than half the cases.
No change in the degree of perspiration of the palms or soles was observed. (d)
Two patients with idiopathic pruritus, observed for several months, were im-
proved. (e) One patient had pruritus associated with the exfoliating phase of
the so-called atabrine dermatitis. Benadryl was of value in this case, and it is
suggested that it be used in more of these cases. (1) Three patients with "id"
reactions with dermatophytosis were treated with varying results. (g) One case
of seborrheic dermatitis with wide-spread lesions on the face, neck, axillary and
pubic areas associated with marked pruritus was definitely helped by Benadryl.
(h) Six of 7 patients with post-scabetic pruritus responded well. (i) A single
case of gastric crises, given Benadryl in large doses, sustained initial transient
relief. After the first few days of treatment no further diminution of the pain
occurred.
SUMMARY AND CONCLUSIONS
Benadryl (beta dimethylaminoethyl benzhydryl ether hydrochloride) is a new
chemical compound said to be capable of "anti-histamine action." Although it
has not produced severe side-reactions, there are some reactions, such as drow-
siness and sleepiness, which do take place quite frequently. Therefore, patients
taking the drug should not be permitted to drive cars, fly planes or work as
trainsmen or engage in similar occupations. No cumulative effects were noted
when the drug was taken over long periods of time. To date, under the advised
dosage of either 50 or 100 milligrams orally, 1 to 6 times a day, Benadryl is only
paffiative. In some cases it appears to be a potent anti-pruritic drug with
prompt action in those patients who are benefit ted. On the other hand the
effects are transient and the signs and symptoms of the diseases under treatment
return shortly after the drug is discontinued.
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Benadryl is a valuable therapeutic agent in the treatment of a certain per-
centage of cases of acute and chronic urticaria, dermographism, and angio-
neurotic edema. It should be tried in any disease that causes these complex
reactions, particularly serum sickness or post-vaccinial reactions of any type.
It was of definite value in the treatment of herpes zoster. Atopic dermatitis
may be improved subjectively but not objectively.
Benadryl is a helpful adjunct in the treatment of dermatitis medicamentosa,
particularly that caused by penicillin; and further investigation into the problem
of Benadryl and drug sensitivity is warranted. The encouraging good effect of
Benadryl on one case of dermatitis herpetiformis warrants further study.
Varying degrees of success were observed in miscellaneous skin diseases and
syndromes associated with pruritus, such as anal and scrotal pruritus, seborrhnic
dermatitis, pityriasis rosea, dysidrosis, dermatophytosis with "id" reactions,
idiopathic pruritus, exfoliating dermatitis, and post-scabetic pruritus. Benadryl
was a failure in mycosis fungoides and of doubtful value in gastric crises.
623 Doctors Bldg.
Cincinnati, Ohio
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